Were the SOPH share sales by Manuela Valente discretionary trades?

No. Footnotes explain the sales were executed under a pre-established Rule 10b5-1 trading plan and do not represent discretionary trades. They were specifically made to cover tax withholding from restricted stock unit vesting, limiting their signaling value about her view of the stock.

What prices were received in Manuela Valente’s SOPH share sales?

The reported weighted average sale prices were $4.8678 and $4.8453 per share. A footnote notes the actual sale prices for individual trades ranged from $4.68 to $5.01, and detailed breakdowns are available upon written request to SOPHiA GENETICS or the SEC staff.

SOPHiA GENETICS (SOPH) officer sells shares to cover RSU taxes

Filing Impact

(Neutral)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

SOPHiA GENETICS SA Chief People Officer Manuela Valente reported open-market sales of company ordinary shares that were made to cover tax obligations from recent restricted stock unit vesting. The transactions, totaling 4,973 shares sold at prices around $4.85 per share, were executed under a pre-established Rule 10b5-1 trading plan.

Following these sales, Valente continues to hold 219,275 ordinary shares directly. Because the trades were specifically to satisfy tax withholding and were pre-planned, they reflect routine administration of equity compensation rather than discretionary buying or selling decisions.

Insights

Sales are pre-planned and tax-driven, indicating routine compensation management.

The filing shows Chief People Officer Manuela Valente sold 4,973 SOPHiA GENETICS ordinary shares in open-market transactions at prices near $4.85 per share. A footnote states these sales were to satisfy tax withholding tied to restricted stock units vesting on April 2 and 3, 2026.

The footnotes also confirm the trades were executed under a pre-established Rule 10b5-1 trading plan and "do not represent discretionary trades." After the transactions, Valente holds 219,275 ordinary shares directly. Given the tax and plan-driven nature, this looks like routine equity compensation administration with limited informational value about her view of the stock.

Insider Trade Summary 10b5-1

Net Seller: 4,973 shares ($24,149)

Net Sell 2 txns

Insider Valente Manuela

Role Chief People Officer

Sold 4,973 shs ($24K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	2,376	$4.8678	$12K
Sale	Ordinary Shares	2,597	$4.8453	$13K

Holdings After Transaction: Ordinary Shares — 219,275 shares (Direct)

Footnotes (1)

Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.68 to $5.01, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold on 2026-04-07: 2,376 shares at $4.8678 Shares sold on 2026-04-06: 2,597 shares at $4.8453 Total shares sold: 4,973 shares +3 more

6 metrics

Shares sold on 2026-04-07 2,376 shares at $4.8678 Open-market sale of ordinary shares

Shares sold on 2026-04-06 2,597 shares at $4.8453 Open-market sale of ordinary shares

Total shares sold 4,973 shares Aggregate of two open-market sales

Post-transaction holding 219,275 shares Ordinary shares held directly after latest sale

Prior holding after earlier sale 221,651 shares Ordinary shares held directly after 2026-04-06 sale

Price range of sales $4.68–$5.01 Range of individual trade prices noted in footnote

Key Terms

restricted stock units, Rule 10b5-1 trading plan, weighted average price

3 terms

restricted stock units financial

"tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Rule 10b5-1 trading plan regulatory

"These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Form 4 Insider Transactions: What Each Field Means →

04/08/2026 - 04:04 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Valente Manuela

(Last)

(First)

(Middle)

C/O SOPHIA GENETICS SA

LA PIECE 12

(Street)

ROLLE

1180

(City)

(State)

(Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
SOPHiA GENETICS SA [ SOPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief People Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	04/06/2026		S		2,597⁽¹⁾	D	$4.8453	221,651	D
Ordinary Shares	04/07/2026		S		2,376⁽¹⁾	D	$4.8678⁽²⁾	219,275	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.68 to $5.01, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Elimara Brunetto as Attorney-in-fact for Manuela Valente	04/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did SOPH Chief People Officer Manuela Valente report?

Manuela Valente reported selling 4,973 SOPHiA GENETICS ordinary shares in two open-market transactions. The shares were sold at prices around $4.85 per share and were linked to tax obligations from vesting restricted stock units, rather than discretionary portfolio decisions.

Why did Manuela Valente sell SOPH shares in this Form 4 filing?

The filing states the shares were sold to satisfy tax withholding obligations from restricted stock units vesting on April 2 and 3, 2026. This means the sales were part of routine equity compensation tax management, not independent investment choices about SOPHiA GENETICS stock.

How many SOPH shares does Manuela Valente hold after these sales?

After completing the reported transactions, Manuela Valente directly holds 219,275 SOPHiA GENETICS ordinary shares. This post-transaction holding shows she retains a sizable equity position in the company despite selling a smaller number of shares to cover tax obligations.